Prognostic effect of beta blockers (BB) in triple-negative breast cancer (TNBC) patients

被引：0
|
作者：
Munzone, Elisabetta
Botteri, Edoardo
Rotmensz, Nicole
Cipolla, Carlo Maria
Zanelotti, Arnaldo
Adamoli, Laura
Viale, Giuseppe
Goldhirsch, Aron
Gandini, Sara
机构：
[1] European Inst Oncol, Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy
[3] European Inst Oncol, Div Med Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1061
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic capability of a TNBC 3-genes score among triple-negative breast cancer subtypes
    Araujo, J.
    Flores, C.
    Schwarz, L.
    Doimi, F.
    Dyer, R.
    Gomez, H.
    Pinto, J.
    BREAST, 2019, 44 : S29 - S29
  • [42] Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?
    Schmidt, Gilda
    Solomayer, Erich-Franz
    Bohle, Rainer Maria
    Gerlinger, Christoph
    Radosa, Julia Caroline
    Endrikat, Jan
    Kasoha, Mariz
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (08) : 2109 - 2116
  • [43] Clinical characteristics and prognostic analysis of triple-negative breast cancer patients
    Yuan, Na
    Meng, Min
    Liu, Caigang
    Feng, Lu
    Hou, Lei
    Ning, Qian
    Xin, Guohong
    Pei, Li
    Gu, Shanzhi
    Li, Xiao
    Zhao, Xinhan
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 245 - 251
  • [44] The prognostic impact of age in patients with triple-negative breast cancer.
    Liedtke, C.
    Gluz, D.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?
    Gilda Schmidt
    Erich-Franz Solomayer
    Rainer Maria Bohle
    Christoph Gerlinger
    Julia Caroline Radosa
    Jan Endrikat
    Mariz Kasoha
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2109 - 2116
  • [46] Effect of cabozantinib treatment on circulating immune cell populations in patients with metastatic triple-negative breast cancer (TNBC).
    Duda, Dan G.
    Ziehr, David R.
    Guo, Hao
    Ng, Mei
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Winer, Eric P.
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Effect of estrogen receptor beta expression (ERβe) in triple-negative breast cancer (TNBC) patients treated in the neoadjuvant GeparTrio trial.
    Heitz, F.
    Sinn, B.
    Loibl, S.
    Du Bois, A.
    Jackisch, C.
    Kuemmel, S.
    Denkert, C.
    Barinoff, J.
    Mehta, K.
    Von Minckwitz, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines
    Jafari, Sevda
    Dabiri, Sheida
    Aghdam, Elnaz Mehdizadeh
    Fathi, Ezzatollah
    Saeedi, Nazli
    Montazersaheb, Soheila
    Farahzadi, Raheleh
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (08): : 2559 - 2568
  • [50] Endocan as a prognostic biomarker of triple-negative breast cancer
    Sagara, Atsunobu
    Igarashi, Katsuhide
    Otsuka, Maky
    Kodama, Akihiro
    Yamashita, Mutsumi
    Sugiura, Rei
    Karasawa, Takeshi
    Arakawa, Kazuhiko
    Narita, Michiko
    Kuzumaki, Naoko
    Narita, Minoru
    Kato, Yoshinori
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 269 - 278
12345